Jennifer R Baker

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Structure Activity Relationship

Perovskite Solar Cells

Breast Cancer Cells

Methicillin Resistant Staphylococcus Aureus

Top Venues

RSC medicinal chemistry

Medicinal research reviews

Chemical communications (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jufeng Sun, Jennifer R Baker, Cecilia C Russell, Hong Ngoc Thuy Pham, Chloe D Goldsmith, Peter J Cossar, Jennette A Sakoff, Christopher J Scarlett, Adam McCluskey
Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer. RSC medicinal chemistry 14 (11) (2023)
Qisi Zhang, Cyrille S Kounde, Milon Mondal, Jake L Greenfield, Jennifer R Baker, Sergei Kotelnikov, Mikhail Ignatov, Christopher P Tinworth, Leran Zhang, Daniel Conole, Elena De Vita, Dima Kozakov, Adam McCluskey, John D Harling, Matthew John Fuchter, Edward William Tate
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs). Chemical communications (Cambridge, England) 58 (78) (2022)
Jennifer R Baker, Peter J Cossar, Mark A T Blaskovich, Alysha G Elliott, Johannes Zuegg, Matthew A Cooper, Peter J Lewis, Adam McCluskey
Amino Alcohols as Potential Antibiotic and Antifungal Leads. Molecules (Basel, Switzerland) 27 (7) (2022)
Andrew J Stevens, Rebecca Abraham, Kelly A Young, Cecilia C Russell, Siobhann N McCluskey, Jennifer R Baker, Bertha Rusdi, Stephen W Page, Ryan O'Handley, Mark A O'Dea, Sam Abraham, Adam McCluskey
Antigiardial Activity of Novel Guanidine Compounds. ChemMedChem 17 (21) (2022)
David T Stanton, Jennifer R Baker, Adam McCluskey, Stefan Paula
Development and interpretation of a QSAR model for in vitro breast cancer (MCF-7) cytotoxicity of 2-phenylacrylonitriles. Journal of computer-aided molecular design 35 (5) (2021)
Jennifer R Baker, Cecilia C Russell, Jayne Gilbert, Adam McCluskey, Jennette A Sakoff
Amino alcohol acrylonitriles as broad spectrum and tumour selective cytotoxic agents. RSC medicinal chemistry 12 (6) (2021)
Jufeng Sun, Joey I Ambrus, Cecilia C Russell, Jennifer R Baker, Peter J Cossar, Melanie J Pirinen, Jennette A Sakoff, Christopher J Scarlett, Adam McCluskey
Targeting the S100A2-p53 Interaction with a Series of 3,5-Bis(trifluoromethyl)benzene Sulfonamides: Synthesis and Cytotoxicity. ChemMedChem 16 (18) (2021)
Jennifer R Baker, Brett L Pollard, Andrew J S Lin, Jayne Gilbert, Stefan Paula, Xiao Zhu, Jennette A Sakoff, Adam McCluskey
Modelling and Phenotypic Screening of NAP-6 and 10-Cl-BBQ, AhR Ligands Displaying Selective Breast Cancer Cytotoxicity in Vitro. ChemMedChem 16 (9) (2021)
Jennifer R Baker, Cecilia C Russell, Jayne Gilbert, Jennette A Sakoff, Adam McCluskey
Amino Alcohol Acrylonitriles as Activators of the Aryl Hydrocarbon Receptor Pathway: An Unexpected MTT Phenotypic Screening Outcome. ChemMedChem 15 (6) (2020)
Jennifer R Baker, Jennette A Sakoff, Adam McCluskey
The aryl hydrocarbon receptor (AhR) as a breast cancer drug target. Medicinal research reviews 40 (3) (2019)
Cecilia C Russell, Andrew J Stevens, Kelly A Young, Jennifer R Baker, Siobhann N McCluskey, Manouchehr Khazandi, Hongfei Pi, Abiodun David Ogunniyi, Stephen W Page, Darren J Trott, Adam McCluskey
Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-Amine with Antibiotic Activity. ChemistryOpen 8 (7) (2019)
Cecilia C Russell, Andrew J Stevens, Hongfei Pi, Manouchehr Khazandi, Abiodun David Ogunniyi, Kelly A Young, Jennifer R Baker, Siobhann N McCluskey, Stephen W Page, Darren J Trott, Adam McCluskey
Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues. ChemMedChem 13 (23) (2018)
Jennifer R Baker, Jayne Gilbert, Stefan Paula, Xiao Zhu, Jennette A Sakoff, Adam McCluskey
Dichlorophenylacrylonitriles as AhR Ligands That Display Selective Breast Cancer Cytotoxicity in vitro. ChemMedChem 13 (14) (2018)